Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Deraco

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Clinical Colorectal Cancer|September 1, 2023
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal OriginFilippo Ghelardi, Alessandra Raimondi, Federica Morano, et al.
Annals of Surgical Oncology|February 28, 2018
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional ExperienceYang Liu, Yutaka Yonemura, Edward A Levine, et al.
Ebiomedicine|December 25, 2018
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesotheliomaRocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.
The British Journal of Surgery|June 25, 2025
Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensusAditi Bhatt, Artem Stepanyan, Brendan J Moran, et al.
The British Journal of Surgery|June 25, 2025
Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundariesAditi Bhatt, Christina Fotopoulou, Brendan J Moran, et al.
JAMA Surgery|January 27, 2021
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive SurgeryShigeki Kusamura, Francesco Barretta, Yutaka Yonemura, et al.
Tumori|April 13, 2012
Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationaleChristopher Cao, Tristan D Yan, David L Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapyTerence C Chua, Brendan J Moran, Paul H Sugarbaker, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Stop Flow in abdominal and pelvic cancer relapsesRosario Vincenzo Iaffaioli, Gaetano Facchini, Anna Tortoriello, et al.
Journal of Molecular Cell Biology|December 2, 2022
Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastasesLuca Varinelli, Marcello Guaglio, Silvia Brich, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Clinical Colorectal Cancer|September 1, 2023
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal OriginFilippo Ghelardi, Alessandra Raimondi, Federica Morano, et al.
Annals of Surgical Oncology|February 28, 2018
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional ExperienceYang Liu, Yutaka Yonemura, Edward A Levine, et al.
Ebiomedicine|December 25, 2018
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesotheliomaRocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.
The British Journal of Surgery|June 25, 2025
Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensusAditi Bhatt, Artem Stepanyan, Brendan J Moran, et al.
The British Journal of Surgery|June 25, 2025
Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundariesAditi Bhatt, Christina Fotopoulou, Brendan J Moran, et al.
JAMA Surgery|January 27, 2021
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive SurgeryShigeki Kusamura, Francesco Barretta, Yutaka Yonemura, et al.
Tumori|April 13, 2012
Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationaleChristopher Cao, Tristan D Yan, David L Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapyTerence C Chua, Brendan J Moran, Paul H Sugarbaker, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Stop Flow in abdominal and pelvic cancer relapsesRosario Vincenzo Iaffaioli, Gaetano Facchini, Anna Tortoriello, et al.
Journal of Molecular Cell Biology|December 2, 2022
Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastasesLuca Varinelli, Marcello Guaglio, Silvia Brich, et al.
Pageof 18